SEC ownership of MACROGENICS INC

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001125345.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

ARMISTICE CAPITAL, LLC

Comparable rows

50/50

Latest evidence

01 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
ARMISTICE CAPITAL, LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
01 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001125345
Issuer location
Rockville, MD

Ownership snapshot

Top shareholders of MACROGENICS INC (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
50/50
Latest evidence
01 Jun 2026
13F 13D/G Lead comparable stake: 9.5% 13D/G row: ARMISTICE CAPITAL, LLC Showing 1-8 of 50 holder rows.

Quick read

ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 9.5%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership Top 5
ARMISTICE CAPITAL, LLC 9.5%
MILLENNIUM MANAGEMENT LLC 5.4%
BANK OF AMERICA CORP /DE/ 5.1%
WASATCH ADVISORS LP 3.1%
BlackRock, Inc. 2.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARMISTICE CAPITAL, LLC
13F 13D/G
Company
9.5%
from 13D/G
$17,374,680
6,012,000 shares
31 Mar 2026
MILLENNIUM MANAGEMENT LLC
13D/G 13F
Company
5.4%
$12,092,974
3,435,504 shares
+$6,023,614 01 Jun 2026
BANK OF AMERICA CORP /DE/
13D/G 13F
Company
5.1%
$11,730,866
3,258,574 shares
$0 31 Mar 2026
WASATCH ADVISORS LP
13F 13D/G
Company
3.1%
from 13D/G
$4,507,536
1,559,701 shares
31 Mar 2026
BlackRock, Inc.
13F 13D/G
Company
2.9%
from 13D/G
$3,361,492
1,163,146 shares
31 Mar 2026
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
4.7%
$8,564,686
2,963,559 shares
31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
4.2%
$7,669,635
2,653,853 shares
31 Mar 2026
ACADIAN ASSET MANAGEMENT LLC
13F
Company
13F
4%
$7,346,000
2,544,000 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$150,515.

Buys
$150,515
Insiders: 1
Sells
$0
Insiders: 0
Net
+$150,515
Shares: +100,000
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 100,000 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 100,000 0 $150,515 $0 +$150,515

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 21 reporting-owner rows connected to MACROGENICS INC. Open a relationship link for the CIK-to-CIK filing trail.

Rows
21
Largest Forms 3/4/5 holder
BIOTECH TARGET N V
Net 12M change
+$150,515
Latest report
19 May 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
BIOTECH TARGET N V 10%+ Owner $119,159,556 Mixed 02 Oct 2023
Scott Koenig Director $1,678,069 Mixed 19 May 2026
Lynn Cilinski VP, Controller and Treasurer $1,163,583 Mixed 15 Feb 2024
Stephen L. Eck Chief Medical Officer $698,476 Mixed 15 Feb 2025
William K. Heiden Director $499,102 +$150,515 +43% Mixed 18 May 2026
Edward Hurwitz Director $424,116 Mixed 18 May 2026
James Karrels SVP and CFO $390,720 Mixed 12 Feb 2026
David C. Stump Director $328,532 Mixed 18 May 2026
Scott Thomas Jackson Director $328,532 Mixed 18 May 2026
Karen Jean Ferrante Director $328,532 Mixed 18 May 2026
Ezio Bonvini Sr VP, Research & CSO $291,978 Mixed 12 Feb 2026
Federica F. O'Brien Director $271,497 Mixed 18 May 2026
Meenu Chhabra Director $251,497 Mixed 18 May 2026
Margaret Liu Director $221,447 Mixed 18 May 2026
Jay Philip Siegel Director $221,447 Mixed 18 May 2026
Eric Blasius Risser President and CEO, Director $174,620 Mixed 12 Feb 2026
Thomas Spitznagel Sr VP, Technical Ops $100,038 Mixed 12 Feb 2026
Jeffrey Stuart Peters Senior VP, GC, and Secretary $87,319 Mixed 12 Feb 2026
Beth Ann Smith VP, Controller & Treasurer $24,658 Mixed 12 Feb 2026
Kenneth Galbraith Director $22,650 Mixed 13 May 2021

Recent insider transactions for MACROGENICS INC

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Federica F. O'Brien MGNX Restricted Stock Unit Award 3,750 3,750 19 May 2026 Direct
Federica F. O'Brien MGNX Stock Option (right to buy) Award 22,000 22,000 19 May 2026 Direct
Scott Thomas Jackson MGNX Stock Option (right to buy) Award 22,000 22,000 19 May 2026 Direct
Scott Thomas Jackson MGNX Restricted Stock Unit Award 3,750 3,750 19 May 2026 Direct
William K. Heiden MGNX Stock Option (right to buy) Award 22,000 22,000 19 May 2026 Direct
William K. Heiden MGNX Restricted Stock Unit Award 3,750 3,750 19 May 2026 Direct
Margaret Liu MGNX Stock Option (right to buy) Award 22,000 22,000 19 May 2026 Direct
Margaret Liu MGNX Restricted Stock Unit Award 3,750 3,750 19 May 2026 Direct
Meenu Chhabra MGNX Restricted Stock Unit Award 3,750 3,750 19 May 2026 Direct
Meenu Chhabra MGNX Stock Option (right to buy) Award 22,000 22,000 19 May 2026 Direct
Edward Hurwitz MGNX Stock Option (right to buy) Award 22,000 22,000 19 May 2026 Direct
Edward Hurwitz MGNX Restricted Stock Unit Award 3,750 3,750 19 May 2026 Direct
David C. Stump MGNX Stock Option (right to buy) Award 22,000 22,000 19 May 2026 Direct
David C. Stump MGNX Restricted Stock Unit Award 3,750 3,750 19 May 2026 Direct
Karen Jean Ferrante MGNX Stock Option (right to buy) Award 22,000 22,000 19 May 2026 Direct
Karen Jean Ferrante MGNX Restricted Stock Unit Award 3,750 3,750 19 May 2026 Direct
Scott Koenig MGNX Stock Option (right to buy) Award 22,000 22,000 19 May 2026 Direct
Scott Koenig MGNX Restricted Stock Unit Award 3,750 3,750 19 May 2026 Direct
Federica F. O'Brien MGNX Common Stock Options Exercise 34.1% 3,750 14,750 18 May 2026 Direct
Federica F. O'Brien MGNX Restricted Stock Unit Options Exercise -100% -3,750 0 18 May 2026 Direct
Scott Thomas Jackson MGNX Common Stock Options Exercise 34.1% 3,750 14,750 18 May 2026 Direct
Scott Thomas Jackson MGNX Restricted Stock Unit Options Exercise -100% -3,750 0 18 May 2026 Direct
William K. Heiden MGNX Common Stock Options Exercise 3.38% 3,750 114,750 18 May 2026 Direct
William K. Heiden MGNX Restricted Stock Unit Options Exercise -100% -3,750 0 18 May 2026 Direct
Jay Philip Siegel MGNX Common Stock Options Exercise 34.1% 3,750 14,750 18 May 2026 Direct
Jay Philip Siegel MGNX Restricted Stock Unit Options Exercise -100% -3,750 0 18 May 2026 Direct
Margaret Liu MGNX Common Stock Options Exercise 34.1% 3,750 14,750 18 May 2026 Direct
Margaret Liu MGNX Restricted Stock Unit Options Exercise -100% -3,750 0 18 May 2026 Direct
Meenu Chhabra MGNX Common Stock Options Exercise 34.1% 3,750 14,750 18 May 2026 Direct
Meenu Chhabra MGNX Restricted Stock Unit Options Exercise -100% -3,750 0 18 May 2026 Direct
Edward Hurwitz MGNX Common Stock Options Exercise 8.51% 3,750 47,824 18 May 2026 Direct
Edward Hurwitz MGNX Restricted Stock Unit Options Exercise -100% -3,750 0 18 May 2026 Direct
David C. Stump MGNX Common Stock Options Exercise 34.1% 3,750 14,750 18 May 2026 Direct
David C. Stump MGNX Restricted Stock Unit Options Exercise -100% -3,750 0 18 May 2026 Direct
Karen Jean Ferrante MGNX Common Stock Options Exercise 34.1% 3,750 14,750 18 May 2026 Direct
Karen Jean Ferrante MGNX Restricted Stock Unit Options Exercise -100% -3,750 0 18 May 2026 Direct
Ezio Bonvini MGNX Common Stock Tax liability -4.23% -6,433 145,799 15 Feb 2026 Direct
Ezio Bonvini MGNX Common Stock Options Exercise 12.3% 16,665 152,232 15 Feb 2026 Direct
Ezio Bonvini MGNX Restricted Stock Unit Options Exercise -100% -16,665 0 15 Feb 2026 Direct
Beth Ann Smith MGNX Common Stock Tax liability -3.2% -423 12,781 15 Feb 2026 Direct
Beth Ann Smith MGNX Common Stock Options Exercise 9.04% 1,095 13,204 15 Feb 2026 Direct
Beth Ann Smith MGNX Restricted Stock Unit Options Exercise -100% -1,095 0 15 Feb 2026 Direct
James Karrels MGNX Common Stock Tax liability -2.73% -5,790 206,037 15 Feb 2026 Direct
James Karrels MGNX Common Stock Options Exercise 7.62% 14,999 211,827 15 Feb 2026 Direct
James Karrels MGNX Restricted Stock Unit Options Exercise -100% -14,999 0 15 Feb 2026 Direct
Jeffrey Stuart Peters MGNX Common Stock Tax liability -14.2% -5,147 31,105 15 Feb 2026 Direct
Jeffrey Stuart Peters MGNX Common Stock Options Exercise 58.2% 13,332 36,252 15 Feb 2026 Direct
Jeffrey Stuart Peters MGNX Restricted Stock Unit Options Exercise -100% -13,332 0 15 Feb 2026 Direct
Thomas Spitznagel MGNX Common Stock Tax liability -12.5% -5,520 38,543 15 Feb 2026 Direct
Thomas Spitznagel MGNX Common Stock Options Exercise 43.4% 13,332 44,063 15 Feb 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .